Asia-Pacific Point of Care (PoC) Molecular Diagnostics Market Report 2018

SKU ID : QYR- 10873306

Publishing Date : 04-Dec-2017

No. of pages : 107

PRICE
4000
8000


  • In this report, the Asia-Pacific Point of Care (PoC) Molecular Diagnostics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

    Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Point of Care (PoC) Molecular Diagnostics for these regions, from 2012 to 2022 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

    Asia-Pacific Point of Care (PoC) Molecular Diagnostics market competition by top manufacturers/players, with Point of Care (PoC) Molecular Diagnostics sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Bayer Corporation
    Roche Diagnostics
    Sysmex Corporation
    Abaxis
    Abbott Laboratories
    BioMerieux SA
    Bio-Rad Laboratories
    Danaher Corporation
    OraSure Technologies

    On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    Polymerase Chain Reaction (Real Time PCR)
    In Situ Hybridization
    Chips and Microarrays
    Mass Spectrometry
    Sequencing
    Isothermal Amplification
    Others

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospitals
    Diagnostic Laboratories
    Research & Academic Laboratories

    If you have any special requirements, please let us know and we will offer you the report as you want.